Article Text

Download PDFPDF
Cohort study
Vitamin K antagonist-experienced patients with a history of stroke/transient ischaemic attack who switched from warfarin to dabigatran increased their rate of recurrent stroke/transient ischaemic attack compared with those on warfarin

Statistics from Altmetric.com

Footnotes

  • Competing interests JWE has received honoraria from Bayer, BI, BMS, Daiichi-Sankyo, Janssen and Pfizer. JB has received honoraria from BMS and Pfizer.

  • Provenance and peer review Commissioned; internally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.